Home/Publication/Granite & HighLight in AI Drug Discovery Platform
Granite & HighLight in AI Drug Discovery Platform 

12 Aug 2026

US$ 20.00

Granite Asia and HighLight Capital have joined Qiming Venture Partners, MPCi and NRL Capital, all existing investors ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Accel has raised US$3.5 bn in aggregate for four new vehicles for early-stage investments in the USA, Europe, Israel ......

GigaDevice Semiconductor Inc, a China-based fabless semiconductor company with its stock quoted in both the A-share ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.